At 24 weeks, 41.7% of the relapsing participants and 75% of the newly diagnosed patients attained a complete response.

A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys.

Kidney fibrosis, a silent threat, involves scar tissue replacing normal kidney tissue, gradually impairing function. Often ...

Hallie Levine is an award-winning health and medical journalist who frequently contributes to AARP, Consumer Reports, the New York Times, and Health.com. She lives in Fairfield, CT, with her three ...

BENGALURU, India and BRIDGEWATER, N.J., Sept. 17, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary ...